Related Experiment Video
Updated: May 12, 2026

Production and Use of Lentivirus to Selectively Transduce Primary Oligodendrocyte Precursor Cells for In Vitro Myelination Assays
Published on: January 12, 2015
Dehydroevodiamine inhibits PEDV through regulateing ERK1/2 MAPK pathway in Vero cells
Kaiyuan Li1, Huiru Wang1, Tingting Chen1
1College of Veterinary Medicine, China Agricultural University, Beijing, 100193, China; Key Biology Laboratory of Chinese Veterinary Medicine, Ministry of Agriculture and Rural Affairs, Beijing, 100193, China.
Abstract:
Porcine epidemic diarrhea virus (PEDV) results in severe economic losses to the swine industry due to its widespread prevalence and high mortality. Currently, there is no effective treatment against PEDV. New antiviral therapies are urgently needed to control this highly contagious pathogen. In this research, the anti-PEDV activity and mechanism of Dehydroevodiamine (DHED) were investigated in vitro. Our results showed that DHED exerted satisfactory anti-PEDV activity by ameliorating cytopathic effects (CPEs), reducing virus titer, and inhibiting PEDV N protein expression and gene transcription dose-dependently. The antiviral mechanism of DHED is related to its inhibition of the entry, replication, and assembly stages of PEDV life cycle. In addition, DHED can regulate the MAPK signaling pathway, and suppress phosphorylated ERK1/2 activation, thus exerting antiviral effects. In conclusion, our research confirmed the anti-PEDV activity and mechanism of DHED, preliminarily providing a new strategy for anti-PEDV drug development.
Related Concept Videos
Inhibition of Cdk Activity
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Inhibition of CDK Activity
Inhibitors of Viral Protein Synthesis

